Rubaiya Anika | Health | Innovative Research Award

Published on by Research Hypothesis

Innovative Research Award

Rubaiya Anika
Mount Sinai Hospital, United States

Rubaiya Anika
Affiliation Mount Sinai Hospital
Country United States
Documents 1
Subject Area Health
Event International Research Hypothesis Excellence Award
ORCID 0009-0005-9072-732X

Rubaiya Anika is a researcher affiliated with Mount Sinai Hospital in the United States whose documented research contribution addresses environmental exposure and biological aging. Her listed journal article examines urinary organophosphate metabolites in relation to laboratory-derived phenotypic aging acceleration among U.S. adults using data from the National Health and Nutrition Examination Survey (NHANES) covering 1999–2018. The work was published in the International Journal of Environmental Research and Public Health in August 2026 and provides a research contribution at the intersection of environmental health, exposure science, epidemiology, and aging research. [1]

Abstract

The research contribution associated with Rubaiya Anika investigates the relationship between urinary organophosphate metabolites and laboratory-derived phenotypic aging acceleration in U.S. adults. The study, titled Urinary Organophosphate Metabolites and Laboratory-Derived Phenotypic Aging Acceleration in U.S. Adults: Evidence from NHANES 1999–2018, uses population-based NHANES data to examine an environmental exposure question within an aging-related epidemiological framework. The article was published in the International Journal of Environmental Research and Public Health in August 2026 and is identified by DOI 10.3390/ijerph23091126. [1]

Keywords

  • Innovative Research Award
  • Rubaiya Anika
  • Organophosphate metabolites
  • Phenotypic aging
  • Environmental health

Introduction

Environmental exposures are an important area of public-health research because chemical exposures may vary across populations and may be investigated in relation to measurable biological and health outcomes. Organophosphate metabolites measured in urine can serve as biomarkers of exposure to organophosphate compounds, while phenotypic measures of aging can provide quantitative indicators for studying biological aging in epidemiological populations. The reported study brings these concepts together by analyzing nationally collected U.S. health data across multiple NHANES cycles from 1999 through 2018. [1]

Research Profile

Rubaiya Anika is identified in the supplied publication record as an author affiliated with Mount Sinai Hospital, United States. The documented subject area is Health, with the research contribution positioned within environmental and population health. The available publication record contains one indexed document supplied for this recognition profile.[1]

Research Contributions

The principal documented contribution is the study of urinary organophosphate metabolites in relation to laboratory-derived phenotypic aging acceleration. This research connects environmental exposure assessment with an aging-related outcome and uses nationally collected health-survey data as its analytical foundation. [1]

  • Evaluation of urinary organophosphate metabolite measurements as indicators of environmental exposure.
  • Investigation of phenotypic aging acceleration as a measurable aging-related outcome.
  • Use of NHANES data spanning 1999–2018 to support population-based analysis.
  • Integration of environmental epidemiology and biological aging research.[1]

Publications

The available record identifies one journal article associated with Rubaiya Anika:

Urinary Organophosphate Metabolites and Laboratory-Derived Phenotypic Aging Acceleration in U.S. Adults: Evidence from NHANES 1999–2018

The publication lists Rubaiya Anika, Matthew Untalan, Emanuela Taioli, and Stephanie Tuminello as contributors. The DOI provides a persistent identifier for the journal article and supports direct access to its bibliographic record. [1]

Research Impact

The documented research has potential relevance to environmental and population health because it investigates whether measurable environmental exposure biomarkers are associated with an aging-related phenotype in adults. Research of this type can contribute to hypothesis generation, exposure surveillance, and the identification of questions that may warrant further investigation through longitudinal, mechanistic, or experimental studies. [1]

Award Suitability

The documented publication provides a substantive basis for considering Rubaiya Anika for recognition under an Innovative Research Award framework. The work applies an interdisciplinary research approach by connecting environmental exposure biomarkers with a quantitative indicator of phenotypic aging in a U.S. adult population. [1]

  • Research innovation: The study links environmental exposure assessment with laboratory-derived phenotypic aging measures.
  • Interdisciplinary relevance: The research spans environmental health, epidemiology, exposure science, and aging research.
  • Population relevance: NHANES provides a nationally collected U.S. population dataset for epidemiological investigation.
  • Research communication: The work is documented through a peer-reviewed journal publication with a persistent DOI.
  • Future research value: The findings can help motivate additional research into environmental determinants of biological aging.

Conclusion

Rubaiya Anika’s documented research contribution focuses on the relationship between urinary organophosphate metabolites and laboratory-derived phenotypic aging acceleration among U.S. adults using NHANES data from 1999–2018. The resulting publication demonstrates an interdisciplinary approach to environmental and population health research and provides a basis for further investigation of environmental influences on aging-related outcomes. [1]

References

  1. Anika, R., Untalan, M., Taioli, E., & Tuminello, S. (2026). Urinary Organophosphate Metabolites and Laboratory-Derived Phenotypic Aging Acceleration in U.S. Adults: Evidence from NHANES 1999–2018. International Journal of Environmental Research and Public Health, 23(9), 1126.
    https://doi.org/10.3390/ijerph23091126

Karen Allison | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Karen Allison | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr Karen Allison, University of Rochester, United States

Assoc. Prof. Dr. Karen Allison is a dedicated ophthalmologist specializing in glaucoma care 👁️‍🗨️. She holds a Doctor of Medicine from Robert Wood Johnson Medical School (1990) 🎓 and an MBA from George Washington University (2013). Currently at the Flaum Eye Institute, she serves as Glaucoma Service Chief and Fellowship Director 👩‍⚕️. With extensive experience in clinical research and education, Dr. Allison has authored impactful studies on glaucoma, disparities in healthcare, and genetic factors in ocular diseases 📚🧬. Her accolades include Leading Physicians in the World and the Women of Distinction honors 🌟. She’s a passionate advocate for diversity and health equity 💙.

Publication Profile

Orcid

Education

Associate Professor Dr. Karen Allison holds a Doctor of Medicine (M.D.) degree from the University of Medicine and Dentistry of New Jersey (Robert Wood Johnson Medical School), earned in May 1990 🩺📚. Further enhancing her expertise, she pursued a Master of Business Administration (M.B.A.) at The George Washington University in Washington, D.C., graduating in January 2013 🎓💼. With a strong foundation in both medicine and business, Dr. Allison combines her clinical acumen and strategic leadership to excel in academia and healthcare management 🌟🌐. Her interdisciplinary background empowers her to contribute meaningfully to education, research, and organizational development. 🌿📖

Certifications and Professional Experience 

Assoc. Prof. Dr. Karen Allison is a board-certified ophthalmologist with extensive expertise in both private practice and academia. 🌟 Her significant contributions at the Flaum Eye Institute include serving as Glaucoma Fellowship Director and Glaucoma Service Chief, showcasing her leadership and dedication to advancing ophthalmic care. 👁️‍🗨️ With a deep commitment to education and innovation in glaucoma management, she bridges clinical excellence with academic rigor. 📚💡 Dr. Allison’s efforts reflect her unwavering passion for improving patient outcomes and mentoring future ophthalmologists, solidifying her reputation as a respected figure in the field of ophthalmology. 🏥🌿

Editorial Roles and Recognition 

Assoc. Prof. Dr. Karen Allison is a leading figure in ophthalmic research and clinical practice 🌟👁️‍🗨️. Her editorial roles in prestigious journals, including the Cureus Journal of Medical Science and the Journal of Medical Case Reports 📚🖋️, underscore her commitment to advancing the field. Through her peer-reviewed publications in high-impact journals 📰📈, Dr. Allison has made significant contributions to the academic community, fostering innovation and knowledge sharing. Her dedication to excellence in research and clinical care continues to inspire professionals and students alike, driving progress in ophthalmology and beyond 🌐🔬.

Awards and Honors 

Assoc. Prof. Dr. Karen Allison is a distinguished ophthalmologist honored with multiple accolades for her contributions to the field and community. She was featured in the Nationwide Registries Women of Distinction Honors Edition in 2021, and recognized as one of the Leading Physicians in the World in 2013. Dr. Allison was named a Top Ophthalmologist in New York in 2013 and 2014. Her dedication to community service earned her awards from the Lions Club of Brooklyn-Kings County in 2013 and the St. Kitts Organization in 2007. 🌟👩‍⚕️🏅🌍

Research Supervision and Mentorship 

Assoc. Prof. Dr. Karen Allison is dedicated to shaping the next generation of researchers. Her commitment shines through her creation of the glaucoma intern research fellowship, which provides invaluable hands-on experience. Beyond that, she has mentored high school students, medical students, and residents, fostering their growth through guidance and supervision of impactful research. This personalized, nurturing approach to education makes her an exceptional academic mentor, helping students thrive in both clinical and research settings. Her passion for teaching and research mentorship is truly inspiring. 🧑‍🏫🔬👩‍🔬💡📚

Research Focus

Assoc. Prof. Dr. Karen Allison’s research primarily focuses on ocular health disparities, particularly glaucoma and age-related macular degeneration (AMD). Her work examines racial, ethnic, and gender disparities in eye care access and treatment, analyzing patterns in gene expression and clinical outcomes across different populations. She evaluates the impact of socioeconomic factors on the utilization of eye care services, leveraging data from sources like the CDC’s Behavioral Risk Factor Surveillance System. Her studies also delve into the genetic underpinnings of eye diseases, seeking to better understand variations in macular tissues and their role in AMD progression. 👁️📊🧬👩‍🔬

Publication Top Notes

Risk factors affecting the utilization of eye care services evaluated by the CDC’s behavior risk factor surveillance system from 2018 to 2021

Uveal effusion syndrome: a case report

Racial and Gender Disparities for Glaucoma Treatment Rates in Upstate New York

Patterns of Gene Expression, Splicing, and Allele-Specific Expression Vary among Macular Tissues and Clinical Stages of Age-Related Macular Degeneration

Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials A Systematic Review and Meta-analysis

Russka Shumnalieva | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Russka Shumnalieva | Medicine and Health Sciences | Best Researcher Award

Assist Prof Dr Russka Shumnalieva, Medical University-Sofia, Bulgaria, Bulgaria

Based on the details provided, Assist. Prof. Dr. Russka Shumnalieva appears to be a strong candidate for a Best Researcher Award.

Publication profile 

Orcid

  1. Expertise in Rheumatology: Dr. Shumnalieva has extensive experience in rheumatology, working at the largest university clinic for rheumatic diseases in Bulgaria. Her PhD thesis focuses on epigenetic modifications and their relation to rheumatic diseases, demonstrating in-depth research in disease mechanisms.
  2. Clinical Integration: Her research not only addresses theoretical aspects but also their application in clinical practice. Her work includes utilizing advanced techniques such as MSUS, capillaroscopy, and mini-invasive arthroscopy, showcasing her hands-on expertise in treating and monitoring patients.
  3. Translational Medicine Experience: Her fellowship at GBRC (Glasgow) and AMC (Amsterdam) provided her valuable experience in translational medicine, bridging the gap between laboratory research and clinical application.
  4. COVID-19 Research Contributions: Dr. Shumnalieva has co-authored significant research papers in top-tier journals, contributing to global studies on COVID-19 and its impact on autoimmune diseases, which underscores her relevance in current medical challenges.
  5. Multidisciplinary Collaborations: Her publications involve multidisciplinary, international collaborations on critical topics such as coronary artery diseases in vasculitides, multimorbidity in inflammatory myopathies, and lung involvement in systemic sclerosis.
  6. Public Health and Patient Care: With a Master’s in Public Health, Dr. Shumnalieva also explores the correlation between risk factors and rheumatic diseases, adding a valuable population health perspective to her research.
  7. Publication Record: With a solid portfolio of peer-reviewed articles in highly respected journals like Rheumatology International and International Journal of Rheumatic Diseases, Dr. Shumnalieva’s research addresses critical issues like the effect of multimorbidity on quality of life and disease flares post-COVID-19 infection.

    Publication top notes

    Flares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD study

    Management of Coronary Artery Diseases in Systemic Vasculitides: Complications and Strategies

    The impact of multimorbidity on QoL in inflammatory myopathies: COVAD cluster analysis

    Lung Involvement in Systemic Sclerosis—From Pathogenesis to Prediction

    Exploring the Role of the Microbiome in Rheumatoid Arthritis—A Critical Review

    In the Pursuit of Precision: Novel Target Therapies Revolutionizing SLE Care

    Conclusion

    Dr. Shumnalieva’s extensive research background, innovative approaches to rheumatology, and contributions to understanding the intersection of autoimmune diseases and COVID-19 make her a standout candidate for the Best Researcher Award.